Vanguard Group Inc Surmodics Inc Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Surmodics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 810,185 shares of SRDX stock, worth $30.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
810,185
Previous 798,675
1.44%
Holding current value
$30.7 Million
Previous $24.4 Million
1.28%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding SRDX
# of Institutions
144Shares Held
12.5MCall Options Held
103KPut Options Held
212K-
Black Rock Inc. New York, NY1.17MShares$44.4 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY850KShares$32.2 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT789KShares$29.9 Million1.82% of portfolio
-
Morgan Stanley New York, NY656KShares$24.9 Million0.0% of portfolio
-
Readystate Asset Management LP Chicago, IL434KShares$16.4 Million0.39% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $531M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...